PT027 (albuterol/budesonide) is a potential first-in-class inhaled, fixed-dose combination of the short-acting beta2-agonist albuterol and budesonide, an inhaled corticosteroid. It is currently ...
About The Study: In this network meta-analysis of patients with asthma, inhaled corticosteroids combined with formoterol and inhaled corticosteroids combined with short-acting β agonists were ...
It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...